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Rat LTXTo the Editor:
We would like to report some new insights into the role of donor
leukocytes in liver transplantation (LTX). Clinical LTX is known to be
unique in the context of solid organ transplantation in that the
incidence of chronic rejection is much lower compared to other organ
grafts [1]. Approximately 20% of stable recipients can be weaned from
immunosuppressive medication without developing graft rejection
[2]. Rat models have shown that liver allografts are accepted without
immunosuppression in many fully major histocompatibility complex
(MHC)-mismatched strain combinations [3]. Furthermore, co-trans-
plantation of a liver allograft can prevent rejection of other organ
grafts from the same donor strain [3]. LTX from the fully MHC-
mismatched PVG donor to DA recipient does not lead to rejection,
whereas other organ allografts (skin, heart and kidney) in the same
strain combination induce acute graft rejection [3]. Importantly,
passenger leukocytes were found to be involved in this phenomenon
of spontaneous liver allograft acceptance [4,5], since irradiation of the
donor liver, which resulted in depletion of most donor leukocytes,
converted spontaneous acceptance to rejection [5]. Conversely, post
transplant administration of donor leukocytes (T cells, B cells, myeloid
cells and NK cells) into the recipient reconstituted long-term survival
after donor irradiation [6,7].⁎ Corresponding author. Laboratory of Gastroenterology and Hepatology, Room L-
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Open access under the Elsevier OA license.Liver-resident Natural Killer (NK) cells are among the pool of
donor leukocytes that are transferred into the recipient by LTX. We
observed that in clinical LTX large numbers of donor NK cells with
high cytotoxic potential detach from the liver grafts and migrate into
the recipient [8]. It is plausible that these donor NK cells may prevent
liver graft rejection by killing recipient antigen presenting cells,
thereby limiting the indirect pathway of alloantigen presentation.
They could also inhibit rejection by killing recipient activated T cells,
as is observed in allogeneic bone marrow transplantation [9].
We analysed the role of donor NK cells in the tolerant PVG to DA rat
LTX model by depleting NK cells in the donor prior to LTX. PVG (RT1c)
NK cells efﬁciently lyse DA (RT1a) target cells [10], most likely because
they express an inhibitory Ly-49 receptor unable to recognize RT1a [11],
and may therefore kill recipient antigen presenting cells and/or T cells
upon transfer into DA rats. We hypothesized that, if NK cells were the
main donor leukocyte subset responsible for liver allograft acceptance,
depletion of these cellswould lead to rejection. Intraperitoneal injection
of 100 μg of the anti-NKRP1 (CD161, clone 3.2.3, Thermo Fisher
Scientiﬁc, Scoresby,Australia)monoclonal antibodyeffectively depleted
NKRP1+TCR− and NKRP1+TCR+ cells from liver and spleen of PVG rats,
as was previously reported [12,13]. Twenty-four hours after injecting
the anti-NKRP1 Ab, ﬂow cytometry analysis revealed a decrease of 99%
in NK cells in the liver (from 27.0±6.0% of liver leukocytes in normal
rats, n=6, to0.4±0.1% in treated rats, n=3)and88% inNKTcells (from
4.1±1.9% in normal rats, n=6, to 0.5±0.3% in treated rats, n=3).
Similarly, in the spleen the percentage of NK cells was reduced by 97%
(from 8.7±1.2% of splenocytes in normal rats, n=6, to 0.3±0.3% in
treated rats, n=5) and the percentage of NKT cells by 99% (from 2.7±
0.7 in normal rats, n=6, to 0.03±0.01 in treated rats, n=5).
Importantly, there was no depletion of other leukocyte subsets as T
cells, B cells andmyeloid cells were unaffected by this treatment. Proper
controls with secondary antibody were performed to exclude the
possibility that the apparent NK-cell depletion was due to epitope
competition of the antibodies used for depletion and detection.
Twenty-four hours after i.p. injection of 100 μg of anti-NKRP1 Ab
into PVG rats, their livers were transplanted into DA recipients
(n=4). The recipient rats did not show any signs of distress during
the follow-up period and survived for more than 100 days with
functioning liver grafts, similarly to rats transplantedwith non-NK cell
depleted liver grafts [5]. These results suggest that donor liver NK cells
are not vitally important for induction of liver transplant tolerance in
the PVG to DA rat strain combination. These observations are in line
with a recent study from our group (Moroso et al., submitted for
139Y. van Leest et al. / Transplant Immunology 24 (2011) 138–139publication) in which we found no evidence for a role of donor NK
cells in the outcome of clinical LTX.
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